- Home
- RVYL vs SILO Comparison
RVYL vs SILO Comparison
Compare RVYL & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- SILO
- Stock Information
- Founded
- RVYL 2007
- SILO 2010
- Country
- RVYL United States
- SILO United States
- Employees
- RVYL N/A
- SILO N/A
- Industry
- RVYL Professional Services
- SILO Apparel
- Sector
- RVYL Consumer Discretionary
- SILO Consumer Discretionary
- Exchange
- RVYL Nasdaq
- SILO Nasdaq
- Market Cap
- RVYL 8.2M
- SILO 8.8M
- IPO Year
- RVYL N/A
- SILO N/A
- Fundamental
- Price
- RVYL $0.86
- SILO $0.81
- Analyst Decision
- RVYL Hold
- SILO
- Analyst Count
- RVYL 1
- SILO 0
- Target Price
- RVYL N/A
- SILO N/A
- AVG Volume (30 Days)
- RVYL 26.6K
- SILO 175.9K
- Earning Date
- RVYL 05-13-2025
- SILO 05-16-2025
- Dividend Yield
- RVYL N/A
- SILO N/A
- EPS Growth
- RVYL N/A
- SILO N/A
- EPS
- RVYL N/A
- SILO N/A
- Revenue
- RVYL $55,998,000.00
- SILO $72,102.00
- Revenue This Year
- RVYL $36.61
- SILO $1.86
- Revenue Next Year
- RVYL $26.67
- SILO N/A
- P/E Ratio
- RVYL N/A
- SILO N/A
- Revenue Growth
- RVYL N/A
- SILO N/A
- 52 Week Low
- RVYL $0.69
- SILO $0.72
- 52 Week High
- RVYL $2.40
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- RVYL 37.89
- SILO 35.28
- Support Level
- RVYL $0.87
- SILO $0.71
- Resistance Level
- RVYL $0.97
- SILO $0.85
- Average True Range (ATR)
- RVYL 0.07
- SILO 0.09
- MACD
- RVYL -0.01
- SILO -0.01
- Stochastic Oscillator
- RVYL 0.00
- SILO 21.85
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.